Updated/Latest Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition by Woo and Robinson 2025–2026 Comprehensive Test Bank Questions and Answers for Advanced Pharmacology Nurse Practitioner Prescribing Examination Preparation Clinical D

Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 5th edition Woo Robinson Test Bank T L T L T L L
T L
T T L T L T L T L T L L
T




Chapter 1. The Role of the Nurse Practitioner as Prescriber
L
T L
T L
T L
T L
T T L L
T T L T L




L
T Multiple Choice L
T




Identify the choice that best completes the statement or answers the question.
L
T L
T T L L
T T L L
T L
T T L T L L
T T L




T L 1. Nurse practitioner prescriptive authority is regulated by:
T L T L T L T L T L T L T L



1. The National Council of State Boards of Nursing T L T L L
T T L T L T L T L



2. The U.S. Drug Enforcement Administration L
T T L T L T L



3. The State Board of Nursing for each state L
T L
T L
T T L L
T T L T L



4. The State Board of Pharmacy T L T L T L T L




T L 2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
L
T L
T T L T L L
T T L T L T L L
T T L L
T T L L
T L
T




include: T L



1. Nurses know more about Pharmacology than other prescribers because they take it L
T L
T L
T L
T L
T L
T L
T L
T T L L
T L
T




both in their basic nursing program and in their APRN program.
T L T L T L T L T L T L T L T L T L T L T L



2. Nurses care for the patient from a holistic approach and include the patient in T L L
T T L L
T L
T L
T T L T L T L L
T T L L
T L
T




decision making regarding their care.
T L T L T L T L T L



3. APRNs are less likely to prescribe narcotics and other controlled substances. L
T L
T T L T L L
T L
T T L T L T L T L



4. APRNs are able to prescribe independently in all states, whereas a physician’s L
T T L L
T L
T T L T L L
T L
T L
T L
T L
T




assistant needs to have a physician supervising their practice.
T L T L T L T L T L T L T L T L T L




T L 3. Clinical judgment in prescribing includes:
T L T L T L T L T L



1. Factoring in the cost to the patient of the medication prescribed L
T T L L
T T L L
T L
T T L T L T L T L



2. Always prescribing the newest medication available for the disease process L
T L
T L
T L
T T L T L T L L
T L
T




3. Handing out drug samples to poor patients L
T L
T T L T L T L T L



4. Prescribing all generic medications to cut costs T L T L L
T L
T L
T L
T




T L 4. Criteria for choosing an effective drug for a disorder include:
T L T L T L T L T L T L T L T L T L T L



1. Asking the patient what drug they think would work best for them T L L
T L
T L
T T L T L T L L
T T L L
T T L



2. Consulting nationally recognized guidelines for disease management L
T T L T L T L L
T L
T




3. Prescribing medications that are available as samples before writing a prescription L
T L
T L
T T L T L L
T T L L
T T L L
T




4. Following U.S. Drug Enforcement Administration guidelines for prescribing L
T L
T T L L
T L
T T L T L




T L 5. Nurse practitioner practice may thrive under health-care reform because of:
T L T L T L T L T L T L T L T L T L T L



1. The demonstrated ability of nurse practitioners to control costs and improve patient
L
T T L L
T T L T L T L L
T L
T L
T T L L
T




outcomes T L



2. The fact that nurse practitioners will be able to practice independently
L
T L
T T L L
T T L L
T T L T L T L L
T




3. The fact that nurse practitioners will have full reimbursement under health-
L
T L
T L
T T L T L L
T L
T L
T L
T L
T




care reform T L



4. The ability to shift accountability for Medicaid to the state level
L
T T L L
T L
T T L L
T T L T L T L L
T

,Chapter 1. The Role of the Nurse Practitioner as Prescriber
L
T L
T L
T L
T L
T L
T L
T L
T T L



Answer Section
L
T L
T




MULTIPLE CHOICE L
T




1. ANS:
L
T 3 PTS: 1
2. ANS:
L
T 2 PTS: 1
3. ANS:
L
T 1 PTS: 1
4. ANS:
L
T 2 PTS: 1
5. ANS:
L
T 1 PTS: 1

,Chapter 2. Review of the Basic Principles of Pharmacology
T L T L L
T L
T L
T T L T L T L




Multiple Choice L
T




Identify the choice that best completes the statement or answers the question.
L
T L
T T L L
T T L L
T L
T T L L
T T L L
T




T L 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to
L
T L
T T L L
T T L L
T L
T L
T L
T L
T T L T L L
T




prescribing because:
T L T L



1. Distribution of drugs to target tissue may be affected. L
T T L T L L
T T L T L T L L
T




2. The solubility of the drug will not match the site of absorption. L
T T L T L L
T T L T L L
T T L T L L
T T L



3. There will be less free drug available to generate an effect. L
T L
T L
T T L L
T T L T L T L T L T L



4. Drugs bound to albumin are readily excreted by the kidneys. L
T T L T L T L L
T T L T L T L T L




T L 2. Drugs that have a significant first-pass effect:
T L T L T L T L T L T L T L



1. Must be given by the enteral (oral) route only L
T T L T L T L T L T L T L T L



2. Bypass the hepatic circulation T L T L L
T




3. Are rapidly metabolized by the liver and may have little if any desired action
L
T T L L
T T L L
T T L T L T L L
T T L T L L
T L
T




4. Are converted by the liver to more active and fat-soluble formsL
T T L T L T L T L T L L
T T L T L T L




T L T L 3. The route of excretion of a volatile drug will likely be the:
T L T L T L T L T L T L T L T L T L T L T L T L



1. Kidneys
2. Lungs
3. Bile and feces L
T L
T




4. Skin

T L 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a storage
L
T L
T L
T L
T L
T L
T L
T L
T T L L
T L
T




reservoir of the drug. Storage reservoirs:
T L T L T L T L T L T L



1. Assure that the drug will reach its intended target tissue T L L
T L
T T L L
T T L T L T L T L



2. Are the reason for giving loading doses L
T L
T T L T L L
T T L



3. Increase the length of time a drug is available and active L
T L
T T L T L L
T L
T L
T T L T L T L



4. Are most common in collagen tissues L
T T L T L L
T T L




T L T L 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
T L T L T L T L T L T L T L T L T L T L T L T L T L T L T L



1. Propensity to go to the target receptor T L T L T L T L L
T T L



2. Biological half-life L
T




3. Pharmacodynamics
4. Safety and side effects T L T L L
T




T L 6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
T L T L L
T T L T L L
T L
T T L L
T L
T L
T L
T L
T L
T T L L
T T L L
T




prescription. This is considered a loading dose. A loading dose:
T L T L T L T L T L T L T L T L T L T L



1. Rapidly achieves drug levels in the therapeutic range T L L
T L
T T L L
T L
T T L



2. Requires four- to five-half-lives to attain L
T L
T L
T L
T T L



3. Is influenced by renal function L
T T L T L T L



4. Is directly related to the drug circulating to the target tissues
L
T T L T L T L T L T L L
T T L L
T T L




T L 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect
T L L
T T L L
T T L T L T L T L L
T T L L
T T L L
T L
T T L T L L
T T L



is the: T L T L



1. Minimum adverse effect level T L T L T L



2. Peak of action L
T T L

, 3. Onset of action T L T L



4. Therapeutic range L
T




T L 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
T L T L T L T L T L T L T L T L T L T L T L T L T L T L



1. When the drug has a wide therapeutic range T L T L T L T L L
T T L T L



2. When the drug will be administered for a short time only T L T L T L L
T T L T L L
T T L T L T L



3. When there is a high correlation between the dose and saturation of receptor sites T L L
T T L L
T T L T L T L L
T L
T L
T T L L
T T L



4. To determine if a drug is in the therapeutic range L
T T L L
T L
T L
T T L T L L
T L
T




T L T L 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration.
T L T L T L T L T L T L T L T L T L T L T L T L T L T L T L T L L
T




This means that the: L
T L
T L
T




1. Concentration will produce therapeutic effects T L L
T T L T L



2. Concentration will produce an adverse response T L T L L
T T L T L



3. Time between doses must be shortened L
T T L T L L
T T L



4. Duration of action of the drug is too long T L T L T L L
T T L T L T L L
T




T L 10. Drugs that are receptor agonists may demonstrate what property?
T L T L T L T L T L T L T L T L T L



1. Irreversible binding to the drug receptor site T L T L T L T L L
T T L



2. Upregulation with chronic use T L L
T L
T




3. Desensitization or downregulation with continuous use T L T L L
T L
T T L



4. Inverse relationship between drug concentration and drug action L
T T L T L L
T L
T T L L
T




T L 11. Drugs that are receptor antagonists, such as beta blockers, may cause:
T L T L T L T L T L T L T L T L T L T L T L



1. Downregulation of the drug receptor T L T L T L T L



2. An exaggerated response if abruptly discontinued L
T T L T L T L L
T




3. Partial blockade of the effects of agonist drugs L
T T L T L T L T L T L T L



4. An exaggerated response to competitive drug agonists L
T T L L
T L
T T L T L




T L 12. Factors that affect gastric drug absorption include:
T L T L T L T L T L T L T L



1. Liver enzyme activity L
T L
T




2. Protein-binding properties of the drug molecule T L T L L
T T L T L



3. Lipid solubility of the drug T L T L T L T L



4. Ability to chew and swallow T L T L T L L
T




T L 13. Drugs administered via IV:
T L T L T L T L



1. Need to be lipid soluble in order to be easily absorbed T L T L L
T T L L
T L
T T L T L T L T L



2. Begin distribution into the body immediately L
T T L L
T T L T L



3. Are easily absorbed if they are nonionized L
T T L T L L
T T L T L



4. May use pinocytosis to be absorbed L
T L
T T L L
T T L




T L 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is:
T L T L T L T L T L T L T L L
T T L T L T L L
T T L L
T T L T L T L T L L
T




1. The sum of the effects of each drug individually L
T T L T L T L T L T L L
T T L



2. Greater than the sum of the effects of each drug individually T L T L L
T T L T L T L T L T L T L T L



3. Less than the effect of each drug individually L
T T L T L L
T T L L
T T L



4. Not predictable, as it varies with each individual L
T T L T L L
T T L L
T T L




T L 15. Which of the following statements about bioavailability is true?
T L T L T L T L T L T L T L T L T L



1. Bioavailability issues are especially important for drugs with narrow therapeutic L
T T L L
T L
T T L L
T L
T L
T L
T




ranges or sustained-release mechanisms.
T L T L T L T L




2. All brands of a drug have the same bioavailability. L
T T L T L L
T L
T T L L
T T L



3. Drugs that are administered more than once a day have greater bioavailability than L
T T L L
T L
T T L T L L
T T L T L L
T T L L
T